| dna metabolic process | GO:0006259 | 303 | 0.296 | |
| nuclear division | GO:0000280 | 158 | 0.157 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.129 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.125 | |
| organelle fission | GO:0048285 | 170 | 0.109 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.103 | |
| response to cell cycle checkpoint signaling | GO:0072396 | 1 | 0.103 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.095 | |
| organelle assembly | GO:0070925 | 177 | 0.087 | |
| dna repair | GO:0006281 | 107 | 0.074 | |
| dna recombination | GO:0006310 | 92 | 0.063 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.061 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.059 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.059 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.052 | |
| male meiosis | GO:0007140 | 37 | 0.051 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.051 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.049 | |
| microtubule polymerization or depolymerization | GO:0031109 | 26 | 0.047 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.046 | |
| endomembrane system organization | GO:0010256 | 147 | 0.046 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.044 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.043 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.043 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.042 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.041 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.041 | |
| double strand break repair | GO:0006302 | 48 | 0.041 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.041 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.041 | |
| protein catabolic process | GO:0030163 | 221 | 0.041 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.040 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.040 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.039 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.038 | |
| chromatin organization | GO:0006325 | 206 | 0.038 | |
| microtubule based process | GO:0007017 | 236 | 0.037 | |
| protein complex disassembly | GO:0043241 | 40 | 0.037 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.037 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.036 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.036 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.035 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.035 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.035 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.034 | |
| male gamete generation | GO:0048232 | 285 | 0.034 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.034 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.034 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.033 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.032 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.032 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.032 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.031 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.031 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.031 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.031 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.030 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.030 | |
| response to radiation | GO:0009314 | 165 | 0.030 | |
| t cell activation | GO:0042110 | 289 | 0.030 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.030 | |
| metaphase plate congression | GO:0051310 | 2 | 0.029 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.029 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.029 | |
| cell division | GO:0051301 | 120 | 0.029 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.028 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.028 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.028 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.028 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.028 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.028 | |
| protein processing | GO:0016485 | 163 | 0.027 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.027 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.027 | |
| oxidation reduction process | GO:0055114 | 342 | 0.027 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.027 | |
| transmembrane transport | GO:0055085 | 412 | 0.027 | |
| protein ubiquitination | GO:0016567 | 171 | 0.026 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.026 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.026 | |
| intracellular protein transport | GO:0006886 | 204 | 0.026 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.026 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.026 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.026 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.025 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.025 | |
| organelle localization | GO:0051640 | 179 | 0.025 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.024 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.024 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.024 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.024 | |
| cell fate commitment | GO:0045165 | 210 | 0.024 | |
| cleavage furrow formation | GO:0036089 | 2 | 0.024 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.024 | |
| cytokinetic process | GO:0032506 | 2 | 0.024 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.024 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.023 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.023 | |
| centrosome cycle | GO:0007098 | 23 | 0.023 | |
| protein depolymerization | GO:0051261 | 34 | 0.023 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.023 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.022 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.022 | |
| gland development | GO:0048732 | 330 | 0.022 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.022 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.022 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.022 | |
| b cell activation | GO:0042113 | 161 | 0.022 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.022 | |
| cellularization | GO:0007349 | 1 | 0.021 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| spermatogenesis | GO:0007283 | 284 | 0.021 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.021 | |
| dna biosynthetic process | GO:0071897 | 22 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| skeletal system development | GO:0001501 | 356 | 0.021 | |
| synaptic transmission | GO:0007268 | 329 | 0.021 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.020 | |
| maintenance of location | GO:0051235 | 89 | 0.020 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.020 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.020 | |
| dna endoreduplication | GO:0042023 | 4 | 0.020 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.020 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.020 | |
| amine metabolic process | GO:0009308 | 45 | 0.020 | |
| chromatin modification | GO:0016568 | 187 | 0.020 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.020 | |
| centrosome duplication | GO:0051298 | 16 | 0.019 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.019 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.019 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.019 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.019 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.019 | |
| cation transport | GO:0006812 | 399 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.018 | |
| chromosome segregation | GO:0007059 | 48 | 0.018 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.018 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.018 | |
| cilium assembly | GO:0042384 | 81 | 0.018 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.018 | |
| spindle assembly involved in meiosis | GO:0090306 | 4 | 0.017 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.017 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.017 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.017 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.017 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.017 | |
| liver development | GO:0001889 | 66 | 0.017 | |
| protein maturation | GO:0051604 | 176 | 0.017 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.017 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.017 | |
| histone modification | GO:0016570 | 159 | 0.017 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.017 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.017 | |
| regulation of cell division | GO:0051302 | 76 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.017 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.016 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.016 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.016 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.016 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.016 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.016 | |
| camera type eye development | GO:0043010 | 266 | 0.016 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.016 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.016 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.016 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.016 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.016 | |
| microtubule nucleation | GO:0007020 | 2 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.015 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.015 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.015 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.015 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.015 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.015 | |
| gene silencing | GO:0016458 | 38 | 0.015 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.015 | |
| spindle assembly involved in mitosis | GO:0090307 | 4 | 0.015 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.015 | |
| heart morphogenesis | GO:0003007 | 178 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.015 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.015 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.015 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.015 | |
| extracellular structure organization | GO:0043062 | 148 | 0.015 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.015 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.014 | |
| regulation of protein binding | GO:0043393 | 60 | 0.014 | |
| cell adhesion | GO:0007155 | 329 | 0.014 | |
| membrane organization | GO:0061024 | 245 | 0.014 | |
| rhythmic process | GO:0048511 | 174 | 0.014 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.014 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.014 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.014 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.014 | |
| peptide secretion | GO:0002790 | 114 | 0.014 | |
| meiosis i | GO:0007127 | 60 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| centrosome organization | GO:0051297 | 26 | 0.014 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.014 | |
| nucleus organization | GO:0006997 | 45 | 0.014 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.014 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.014 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.014 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.014 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.014 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.014 | |
| regulation of cell activation | GO:0050865 | 289 | 0.014 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.014 | |
| sister chromatid cohesion | GO:0007062 | 12 | 0.014 | |
| female sex differentiation | GO:0046660 | 84 | 0.013 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.013 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.013 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.013 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.013 | |
| male gonad development | GO:0008584 | 88 | 0.013 | |
| nuclear transport | GO:0051169 | 139 | 0.013 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.013 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.013 | |
| microtubule depolymerization | GO:0007019 | 15 | 0.013 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.013 | |
| regulation of protein localization | GO:0032880 | 231 | 0.013 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.013 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.013 | |
| rna processing | GO:0006396 | 105 | 0.013 | |
| endocytosis | GO:0006897 | 168 | 0.013 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.013 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.013 | |
| adaptive immune response | GO:0002250 | 155 | 0.013 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.013 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.013 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.013 | |
| amide transport | GO:0042886 | 138 | 0.013 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.013 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.012 | |
| regulation of binding | GO:0051098 | 111 | 0.012 | |
| developmental maturation | GO:0021700 | 193 | 0.012 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.012 | |
| rna splicing | GO:0008380 | 54 | 0.012 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.012 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.012 | |
| gtp catabolic process | GO:0006184 | 143 | 0.012 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.012 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 34 | 0.012 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.012 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.012 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.012 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.012 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.012 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.012 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.012 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.012 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 20 | 0.012 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.012 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.012 | |
| oogenesis | GO:0048477 | 56 | 0.012 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.012 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.012 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.012 | |
| attachment of spindle microtubules to kinetochore | GO:0008608 | 4 | 0.012 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.012 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.011 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 36 | 0.011 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.011 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.011 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.011 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| placenta development | GO:0001890 | 140 | 0.011 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.011 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.011 | |
| positive regulation of nuclear division | GO:0051785 | 27 | 0.011 | |
| regulation of chromosome segregation | GO:0051983 | 21 | 0.011 | |
| male sex differentiation | GO:0046661 | 109 | 0.011 | |
| protein citrullination | GO:0018101 | 2 | 0.011 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.011 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.011 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.011 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.011 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.011 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.011 | |
| forebrain development | GO:0030900 | 302 | 0.011 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.011 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.011 | |
| molting cycle | GO:0042303 | 90 | 0.011 | |
| spindle assembly | GO:0051225 | 13 | 0.011 | |
| immune effector process | GO:0002252 | 321 | 0.011 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.011 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.011 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.011 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.011 | |
| negative regulation of glycogen biosynthetic process | GO:0045719 | 1 | 0.011 | |
| atp catabolic process | GO:0006200 | 55 | 0.010 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.010 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.010 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.010 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.010 | |
| peptide transport | GO:0015833 | 133 | 0.010 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.010 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.010 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.010 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.010 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.010 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.010 | |
| somatic diversification of immune receptors via somatic mutation | GO:0002566 | 8 | 0.010 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.010 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.010 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.010 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.010 | |
| ossification | GO:0001503 | 216 | 0.010 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.010 | |
| respiratory tube development | GO:0030323 | 167 | 0.010 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.010 | |
